台灣臨床試驗主持人資料庫|TPIDB

2015-08-01 - 2017-07-31

Phase III

A randomized, double-blind, placebo-controlled confirmatory study of the safety and efficacy of ASP015K in patients with rheumatoid arthritis (RA) who had an inadequate response to DMARDs

Condition/Disease

rheumatoid arthritis (RA) who had an inadequate response to DMARDs
Test Drug

ASP015K

Participate Sites
11Sites

Terminated10Sites

方耀凡

Linkou Chang Gung Medical Foundation

Division of Rheumatology

蔡文展

Kaohsiung Municipal Gangshan Hospital

未分科

2016-10-01 - 2020-03-15

Phase III

Condition/Disease
Test Drug

Participate Sites
5Sites

Terminated5Sites

方耀凡

Linkou Chang Gung Medical Foundation

Division of Rheumatology

2018-01-01 - 2020-12-31

Phase III

Efficacy and Safety of Racecadotril in the Treatment of Taiwanese Children Aged 3 to 60 Months Suffering From Acute Diarrhea: A Prospective, Open-label, Multicenter, Single-arm Study.

Condition/Disease

Diarrhea, Infantile
Test Drug

Hidrasec

Participate Sites
3Sites

Terminated3Sites

邱政洵

Linkou Chang Gung Medical Foundation

Division of Pediatrics

2017-04-15 - 2018-08-27

Phase I

A RANDOMIZED, SPONSOR-OPEN, INVESTIGATOR-BLINDED, SUBJECT-BLINDED, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RO7049389 IN: (1) SINGLE- (WITH OR WITHOUT FOOD) AND MULTIPLE- (WITH MIDAZOLAM) ASCENDING DOSES IN HEALTHY VOLUNTEERS; (2) PATIENTS CHRONICALLY INFECTED WITH HEPATITIS B VIRUS

Condition/Disease

HEPATITIS B VIRUS
Test Drug

RO7049389

Participate Sites
7Sites

Recruiting6Sites

葉昭廷

Linkou Chang Gung Medical Foundation

2016-03-01 - 2018-10-31

Phase II

A phase II observer-blind, multicentre, dose-ranging study of children 6 to less than 36 months of age who are to be primed with a 2-dose series of GSK Biologicals’ AS03-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine

Condition/Disease

Active immunization against influenza A virus H5N1 subtype
Test Drug

GlaxoSmithKline (GSK) Biologicals’ Influenza A/Indonesia/05/2005 (H5N1) vaccine adjuvanted with AS03

Participate Sites
8Sites

Terminated7Sites

邱政洵

Linkou Chang Gung Medical Foundation

Division of Pediatrics

2017-09-01 - 2020-01-31

Phase II

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TJ301 (FE 999301) Administered Intravenously in Patients with Active Ulcerative Colitis

Condition/Disease

Ulcerative Colitis
Test Drug

TJ301

Participate Sites
2Sites

Recruiting2Sites

邱正堂

Linkou Chang Gung Medical Foundation

Digestive System Department

2019-03-01 - 2021-10-25

Phase III

A Phase 3, Prospective, Randomized, Double-blind, Placebo-controlled, Multi-region Study to Evaluate the Efficacy, Safety, and Immunogenicity of Inactivated EV71 Vaccine Produced in Vero Cells With Adjuvant in Infants and Children

Condition/Disease

Enterovirus 71 Infection
Test Drug

EV71 Vaccine

Participate Sites
5Sites

Terminated5Sites

邱政洵

Linkou Chang Gung Medical Foundation

Division of Pediatrics

2017-11-01 - 2021-12-08

Phase III

Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial(TRIDENT)

Condition/Disease

Acute primary cerebral hemorrhage
Test Drug

Three-dose combination(telmisartan, amlodipine, indapamide)

Participate Sites
4Sites

Recruiting3Sites

Study ended1Sites

李宗海

Linkou Chang Gung Medical Foundation

Division of Neurology

2016-08-31 - 2018-12-31

Phase II

Multi-center, randomized, vehicle-controlled, investigator-blinded, parallel groups study to evaluate the efficacy and safety of NP000888 in subjects with plaque and nail psoriasis

Condition/Disease

Psoriasis or nail psoriasis
Test Drug

NP000888

Participate Sites
11Sites

Terminated11Sites

李婉若

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Dermatology

2018-11-01 - 2022-04-30

Phase III

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus

Condition/Disease

Systemic Lupus Erythematosus
Test Drug

Baricitinib

Participate Sites
9Sites

Recruiting7Sites

Terminated2Sites

方耀凡

Linkou Chang Gung Medical Foundation

Division of Rheumatology

Search Result

List